相关实验视频

Updated: Jun 26, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

一个协同化学免疫疗法系统,利用PD-L1阻断和生物对等的原药激活

Kewei Wang^1,2,3,4, Maolin Jiang^1,3, Tao Li¹

¹School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, P. R. China.

Advanced materials (Deerfield Beach, Fla.)

|May 8, 2024

概括

这项研究引入了一种新的化疗免疫疗法系统,使用四素修饰的抗PD-L1抗体和多克索鲁比辛前药. 这种方法增强了瘤向和免疫反应,改善了癌症治疗和减少复发.

科学领域:

生物医学工程生物医学工程
癌症研究癌症研究
免疫治疗是一种免疫疗法.

背景情况:

化疗免疫疗法在瘤特异性药物输送和恢复免疫攻击方面面临挑战.
克服当前癌症治疗策略的局限性至关重要.

研究的目的:

开发一种自我增强的化学免疫疗法系统,以提高抗瘤疗效.
改善瘤特异性药物输送和瘤微环境中的免疫反应.

主要方法:

使用四素 (TZ) 修饰的抗PD-L1抗体 (αPD-L1TZ) 和一种TZ可激活的前药物 (多克索鲁比乙烯乙,DOX-VE) 之间的生物对等点击反应.
研究PD-L1阻断和局部前药物激活的协同效应.
评估免疫细胞死亡和免疫记忆的诱导.

主要成果:

αPD-L1TZ有效地破坏PD-L1/PD-1的相互作用,并在现场激活DOX-VE.
激活的DOX调节PD-L1,增强αPD-L1TZ的积累和进一步的前药物激活.
该系统展示了增强的抗瘤疗效,强大的免疫记忆,以及预防瘤复发和转移.

结论:

拟议的化学免疫疗法系统协同结合了PD-L1阻断与生物对等前药激活.
这一策略显著提高了药物输送,瘤向和抗瘤免疫反应.
该系统提供了一种可行的方法,用于有效的化学免疫疗法,具有长期保护作用.

关键词:

生物对等的前药物激活癌症向化疗治疗的化学疗法免疫性细胞死亡免疫性细胞死亡自强化的瘤向向.瘤免疫微环境是一个微环境.

更多相关视频

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...